Found: 25
Select item for more details and to access through your institution.
Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.
- Published in:
- Vox Sanguinis, 2018, v. 113, n. 5, p. 459, doi. 10.1111/vox.12663
- By:
- Publication type:
- Article
Patient outcomes and amotosalen/ UVA-treated platelet utilization in massively transfused patients.
- Published in:
- Vox Sanguinis, 2017, v. 112, n. 3, p. 249, doi. 10.1111/vox.12489
- By:
- Publication type:
- Article
Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study.
- Published in:
- Vox Sanguinis, 2017, v. 112, n. 3, p. 210, doi. 10.1111/vox.12500
- By:
- Publication type:
- Article
Assessment of hemostasis in platelet transfusion clinical trials with differential follow-up.
- Published in:
- Vox Sanguinis, 2012, v. 103, n. 2, p. 179, doi. 10.1111/j.1423-0410.2012.01593.x
- By:
- Publication type:
- Article
Pathogen inactivation of plasma components.
- Published in:
- Vox Sanguinis, 2012, v. 102, n. 2, p. 178, doi. 10.1111/j.1423-0410.2011.01515.x
- By:
- Publication type:
- Article
Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label.
- Published in:
- 2010
- By:
- Publication type:
- Letter
INTERCEPT plasma: comparability with conventional fresh-frozen plasma based on coagulation function – an in vitro analysis.
- Published in:
- Vox Sanguinis, 2010, v. 98, n. 1, p. 47, doi. 10.1111/j.1423-0410.2009.01224.x
- By:
- Publication type:
- Article
Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies.
- Published in:
- 1979
- By:
- Publication type:
- journal article
Acute megakaryoblastic leukemia in childhood.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Concerning Caspari et al: Pathogen Inactivation of Cellular Blood Products More Security for the Patient or Less? Transfus Med Hemother 2003;30:261–263.
- Published in:
- Transfusion Medicine & Hemotherapy, 2005, v. 32, n. 1, p. 45, doi. 10.1159/000082730
- By:
- Publication type:
- Article
Severe thrombocytopenia following intralesional BCG therapy.
- Published in:
- 1978
- By:
- Publication type:
- journal article
Hemostatic Response in Congenital Coagulation Factor-Deficient Patients Transfused with Fresh Frozen Plasma (FFP) Prepared by Helinxä Pathogen Inactivation Technology — The STEP CC Trial.
- Published in:
- Transfusion, 2001, v. 41, p. 89S
- By:
- Publication type:
- Article
Helinx™ Treated RBC Transfusions Are Well Tolerated and Show Comparable Recovery and Survival to Control RBCs.
- Published in:
- Transfusion, 2001, v. 41, p. 38S
- By:
- Publication type:
- Article
Platelets Treated with HELNIX™ Technology (HPC) Are Effective for Multiple Cycles of Transfusion Support of Thrombocytopenia: The euroSPRITE Trial.
- Published in:
- Transfusion, 2001, v. 41, p. 38S
- By:
- Publication type:
- Article
Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: a model of surrogate human hepatitis B virus infectivity.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Functional Characteristics of S-59 Photochemically Treated Platelet Concentrates Derived from Buffy Coats.
- Published in:
- Vox Sanguinis, 2000, v. 79, n. 4, p. 206, doi. 10.1159/000056732
- By:
- Publication type:
- Article
Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 1, p. 1, doi. 10.1038/sj.bmt.1704284
- By:
- Publication type:
- Article
Human platelet arylsulphatases: identification and capacity to destroy SRS-A.
- Published in:
- Immunology, 1979, v. 37, n. 4, p. 723
- By:
- Publication type:
- Article
P‐TS‐76 | Safety and Efficacy of Amotosalen‐UVA Pathogen Reduced Platelet Components Transfused to Mature and Premature Neonates.
- Published in:
- Transfusion, 2023, v. 63, p. 305A, doi. 10.1111/trf.413_17554
- By:
- Publication type:
- Article
P‐TS‐24 | Design of ReCePI, a Randomized, Double‐Blinded, Phase III Study to Evaluate the Efficacy and Safety of Pathogen Reduced RBCs in Complex Cardiac Surgery.
- Published in:
- Transfusion, 2023, v. 63, p. 271A, doi. 10.1111/trf.361_17554
- By:
- Publication type:
- Article
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.
- Published in:
- Transfusion Medicine, 2004, v. 14, n. 4, p. 289, doi. 10.1111/j.0958-7578.2004.00516.x
- By:
- Publication type:
- Article
HOW DO RED CELL ENZYMES AGE? HYPOTHESIS AND FACTS.
- Published in:
- British Journal of Haematology, 1986, v. 64, n. 2, p. 407, doi. 10.1111/j.1365-2141.1986.tb04134.x
- By:
- Publication type:
- Article